Key result
The combination of cardiovascular disease and chronic obstructive pulmonary disease shares common pathogenetic mechanisms including RAAS activation, systemic inflammation, and endothelial dysfunction.
The combination of CVD and COPD shares common risk factors and pathogenetic mechanisms, necessitating a broader approach to diagnosis, risk stratification, and therapy.
The XXI century brought new challenges to clinical medicine. According to several epidemiological studies, the combination of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) is the most common comorbid condition, worsening the quality of life and prognosis. Such dualism of these nosologies is called "cardiorespiratory continuum. The recent worldwide trend is to ascribe common risk factors and pathogenetic mechanisms to cardiovascular disease and COPD bearing in mind the wide spread of smoking habits, obesity, hypertension, and metabolic syndrome. The major common pathogenetic mechanisms include activation of RAAS, persistent systemic inflammation, and endothelial dysfunction. This article provides an overview of common risk factors and pathogenetic mechanisms in the patients presenting with a combination of CVD and COPD in the framework of a broader approach to diagnosis, risk stratification and therapy strategies needed to manage the comorbidity in question.
No takes yet. Share an insight, caveat, or question.
Потешкина et al. (2017) conducted a review in Cardiovascular disease and chronic obstructive pulmonary disease. The combination of cardiovascular disease and chronic obstructive pulmonary disease shares common pathogenetic mechanisms including RAAS activation, systemic inflammation, and endothelial dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: